Junwen Zhou
BSc, MSc, PhD
Senior Researcher
Junwen Zhou joined HERC in October 2020 as Senior Researcher. Junwen’s current work focuses on economic analysis and modelling of chronic diseases using individual participant data from large randomised controlled trials and observational data with focus on cardiovascular disease prevention.
Junwen received his PhD in Clinical Research and Public Health from Aix-Marseille University, France, with thesis focusing on economic modelling with discrete event simulation (DES) in schizophrenia. He received his MSc in Clinical Pharmacy from Peking University, China, with thesis focusing on evidence synthesis with network meta-analysis (NMA) in osteoporosis. He received his BSc in Pharmacy with dual degree in Economics from Peking University, China.
Junwen is experienced in health economic evaluation methods and applications. Prior to his current position, he worked as Modelling Lead in Global Health Economic and Value Assessment (HEVA) in Sanofi, France. Before that, he worked as Research Analyst, then Senior Analyst in Health Economic and Outcome Research (HEOR) in Creativ-Ceutical, France. He also has clinical experience, worked as Clinical Pharmacist Intern in Peking University Third Hospital, China.
Recent publications
-
Evaluation of rivaroxaban-, apixaban- and dabigatran-associated hemorrhagic events using the FDA-Adverse event reporting system (FAERS) database
Guo M. et al, (2021), International Journal of Clinical Pharmacy, 43, 1508 - 1515
-
A model of lifetime health outcomes in cardiovascular disease based on clinical trials and large cohorts
Wu R. et al, (2021), EUROPEAN HEART JOURNAL, 42, 3149 - 3149
-
Incorporating future unrelated medical costs in cost-effectiveness analysis in China.
Jiang S. et al, (2021), BMJ Glob Health, 6
-
Which Criteria are Considered and How are They Evaluated in Health Technology Assessments? A Review of Methodological Guidelines Used in Western and Asian Countries
Wang Y. et al, (2021), Applied Health Economics and Health Policy, 19, 281 - 304
-
Economic burden for Alzheimer’s disease in China from 2010 to 2050: a modelling study
Clay E. et al, (2019), Journal of Market Access & Health Policy, 7, 1667195 - 1667195